United States · FDA National Drug Code directory
Methotrexate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68382-775_5d9b7269-19d4-4d2c-b252-f3ff759dffa5
- Product NDC
- 68382-775
- Form
- TABLET
- Composition / generic term
- Methotrexate
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170209
- Source listing expiry
- 20271231
Source-listed ingredients
- METHOTREXATE — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (68382-775-01) · 68382-775-01
- 500 TABLET in 1 BOTTLE (68382-775-05) · 68382-775-05
- 1000 TABLET in 1 BOTTLE (68382-775-10) · 68382-775-10
- 90 TABLET in 1 BOTTLE (68382-775-16) · 68382-775-16
- 36 TABLET in 1 BOTTLE (68382-775-60) · 68382-775-60
- 100 BLISTER PACK in 1 CARTON (68382-775-77) / 1 TABLET in 1 BLISTER PACK · 68382-775-77
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →